Differential Anti-Fibrotic and Remodeling Responses of Human Dermal Fibroblasts to Artemisia sp., Artemisinin, and Its Derivatives
Molecules · 2024
DOI: 10.3390/molecules29092107 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Pamela Weathers und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology and Biotechnology, Worcester Polytechnic Institute, Worcester, MA 01609, USA. Hauptthemen laut MEDLINE: Artemisinins, Fibroblasts, Artemisia, Fibrosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCCIH NIH HHS, atelier temenos, National Center for Complementary and Integrative Health partially.
Abstract (Originalsprache)
Fibrosis is a ubiquitous pathology, and prior studies have indicated that various artemisinin (ART) derivatives (including artesunate (AS), artemether (AM), and dihydroartemisinin (DHA)) can reduce fibrosis in vitro and in vivo. The medicinal plant Artemisia annua L. is the natural source of ART and is widely used, especially in underdeveloped countries, to treat a variety of diseases including malaria. A. afra contains no ART but is also antimalarial. Using human dermal fibroblasts (CRL-2097), we compared the effects of A. annua and A. afra tea infusions, ART, AS, AM, DHA, and a liver metabolite of ART, deoxyART (dART), on fibroblast viability and expression of key fibrotic marker genes after 1 and 4 days of treatment. AS, DHA, and Artemisia teas reduced fibroblast viability 4 d post-treatment in up to 80% of their respective controls. After 4 d of treatment, AS DHA and Artemisia teas downregulated ACTA2 up to 10 fold while ART had no significant effect, and AM increased viability by 10%. MMP1 and MMP3 were upregulated by AS, 17.5 and 32.6 fold, respectively, and by DHA, 8 and 51.8 fold, respectively. ART had no effect, but A. annua and A. afra teas increased MMP3 5 and 16-fold, respectively. Although A. afra tea increased COL3A1 5 fold, MMP1 decreased >7 fold with no change in either transcript by A. annua tea. Although A. annua contains ART, it had a significantly greater anti-fibrotic effect than ART alone but was less effective than A. afra. Immunofluorescent staining for smooth-muscle α-actin (α-SMA) correlated well with the transcriptional responses of drug-treated fibroblasts. Together, proliferation, qPCR, and immunofluorescence results show that treatment with ART, AS, DHA, and the two Artemisia teas yield differing responses, including those related to fibrosis, in human dermal fibroblasts, with evidence also of remodeling of fibrotic ECM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology and Biotechnology, Worcester Polytechnic Institute, Worcester, MA 01609, USA.
ORCID-Profile: Bushra Hafeez Kiani, David Dolivo
Förderung
- NCCIH NIH HHS
- atelier temenos
- National Center for Complementary and Integrative Health partially
Zitieren
APA
Weathers, P., Towler, M., Kiani, B. H., Dolivo, D., & Dominko, T. (2024). Differential Anti-Fibrotic and Remodeling Responses of Human Dermal Fibroblasts to Artemisia sp., Artemisinin, and Its Derivatives. Molecules. https://doi.org/10.3390/molecules29092107
Vancouver
Weathers P, Towler M, Kiani BH, Dolivo D, Dominko T. Differential Anti-Fibrotic and Remodeling Responses of Human Dermal Fibroblasts to Artemisia sp., Artemisinin, and Its Derivatives. Molecules. 2024. doi:10.3390/molecules29092107
BibTeX
@article{Weathers2024,
author = {Weathers, Pamela and Towler, Melissa and Kiani, Bushra Hafeez and Dolivo, David and Dominko, Tanja},
title = {Differential Anti-Fibrotic and Remodeling Responses of Human Dermal Fibroblasts to Artemisia sp., Artemisinin, and Its Derivatives},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29092107}
}
EUVIMED